1. Field of Invention
This invention relates generally to suturing devices for tissue defects, and more specifically to an improved system to facilitate the closure of the small tissue defects created by physicians for access to operative sites.
2. Background
The field of surgery was revolutionized in 1987 when a cholecystectomy was performed through very small incisions using a camera by Dr. Phillippe Mouret. Soon after that first procedure Dr. Francois Dubois introduced the concept of the trocar to facilitate access to the abdominal cavity allowing for minimal access surgery. Interest in the field and the number of procedures performed laparoscopically spread like wildfire, providing significant advantages to the patient over open procedures. Patients had shorter hospital stays, less pain, and smaller less disfiguring scars, with the result that patients were requesting their procedures to be done laparoscopically. With increasing demand from the patients, and interest from physicians, numerous innovations were made to improve the procedure and address the new specific complications associated with minimal access surgery.
A key component to performing laparoscopic surgery is obtaining access to the operating space by the placement of a trocar. One of the most difficult, time-consuming, and sometimes unreliable parts of the case is closing these incisions, especially in obese patients. This is mainly because these incisions are very small and the layer that needs to be closed (fascia) rests deep underneath the skin and fat tissue of the abdominal wall. The goal is to close these port sites which may range in sizes from 5 mm to 25 mm without enlarging the skin incision, without injuring the intracorporeal contents (i.e. the bowel in the abdominal cavity), and ensuring good fascial closure in a timely manner.
Fascial closure is instrumental in preventing the possibility of life threatening complications. Port or trocar site hernia is a recognized complication of laparoscopy with an incidence ranging from 0.23% to 3.10% depending on the study. This incidence only represents those patients who seek medical attention for symptomatic hernias. Patients with trocar site hernias present with symptoms ranging from unsightly bulges to the more life threatening incarceration of bowel. Typically when patients present with signs of an obstruction due to hernias, they must be repaired surgically and may require a small bowel resection. In rare cases, obese patients may develop a Richter's hernia where only parts of the small bowel are incarcerated in the hernia. These patients do not present with the classical symptoms of obstruction often leading to a missed or delayed diagnosis resulting in increased morbidity.
The pathogenesis of a trocar site hernia is multifactorial including poor closure technique, poor visualization, patient co morbidities including wound infection, diabetes, obesity, poor nutrition, or merely the decision to not close the trocar site. Trocar sites tend to be difficult to close, especially in obese patients, due to the fact that the depth of the incision does not allow proper visualization of the fascia in these incisions. The lack of visualization and the degree of frustration either leads the physician to decide not to close the port site or to attempt a suboptimal closure which may take more time than what the physician would prefer to spend (sometimes up to 20 minutes). Current techniques of closure can also be dangerous since intra-abdominal organs may be injured upon entry to the abdominal cavity or the bite size of fascia at each side of the wound may be too small, leading to a suboptimal closure and potential breakdown of the closure. Therefore there is a need for an improved, automatic, reliable, safe, and quick method to close trocar or port sites following laparoscopic surgery.
There is an ongoing debate concerning which size trocar sites should be closed and which can be left open. The majority of clinicians believe any port site 10 mm or larger made in the midline linea alba or lateral ports below the arcuate line should be closed in adults. In addition, most clinicians agree that any port 5 mm or larger should be closed in children. This decision has been made with reports of hernias occurring in people with port sites smaller than 10 mm. Some clinicians have suggested closing smaller trocar sites in adults if there was significant manipulation of the site during the surgery. The reality is that by not closing these sites, patients are being placed at an increased risk of a re-operation and possibly a life threatening problem.
Currently, clinicians have limited options for closing laparoscopic trocar sites. Most of the devices currently on the market are either more complicated than the standard techniques or place the patient and or physician at risk for injury. In the standard and most popular technique, a needle driver is used to drive a curved needle attached to a suture through the fascia on either side of the port site. This method is challenging due to limited visualization through a small hole. In addition, the contents of the abdominal cavity are at risk of injury since the needle is driven through the fascia blindly. Some physicians use protection devices such as a groove director, but these do not guarantee an adequate bite of fascia necessary for a strong closure. For this reason the Carter Thompson system was developed which uses a standardized needle director to ensure adequate bites of fascia for a strong closure. Unfortunately, this device requires direct visualization from the camera, requires removing the trocar and losing the pneumoperitoneum necessary for use and visualization, and requires multiple passes of needle to deliver the suture. This complicated system improved the chances of a good closure but took a lot longer to carry out due to the number of steps and technical skill required.
A number of attempts over the past 20 years have been made to develop a device to aid in closure of these port sites and address the inadequacies of current devices. Limited examples of prior art include devices disclosed in U.S. Pat. No. 6,743,241 entitled “Laparoscopic port site fascial closure device”, U.S. Pat. No. 5,364,408 entitled “Endoscopic suture system”, U.S. Pat. No. 5,374,275 entitled “Surgical suturing device and method of use”, and U.S. Pat. No. 6,562,052 entitled “Suturing device and method”. These devices as described prove to be inadequate for fascial closure, primarily due the fact they are unable to obtain adequate tissue adjacent to the defect to provide a strong closure, they are not able to maintain pneumoperitoneum needed for appropriate visualization, they require multiple iterations of placing the instrument through the defect and removing the instrument, and they don't adequately protect either the vital structures in the vicinity of the tissue or the healthcare provider from risk of injury. As can be seen there is a need for a more reliable, safe and quick method for fascial closure.
This invention is an improved system to facilitate the closure of tissue defects created by the insertion of a trocar, sheath, or by any other suitable cause. While detail will be provided to aid in the enablement of the device for closure of laparoscopic fascial port sites, this should not limit the disclosure. Any suitable system or method that functions to close a tissue defect in the body may alternatively be used and should be considered within the scope of this disclosure.
The preferred embodiment of the instrument is an elongated device of appropriate diameter that can easily be inserted through the conduit used to create the tissue defect or the tissue defect itself (fascial opening in this case). The device is designed to be in profile where all the features are contained within the diameter of the device. If inserted through the conduit, the conduit (trocar) can then be slid over the entire instrument to remove the conduit without losing pneumoperitoneum.
The instrument has two opposing pivoting extensions at the distal end of the device. When the physician receives the device, it will be in its rest position where the two opposing pivoting extensions are at an angle away from the body of the device. Before placing the device through the conduit or tissue defect, the physician will use the pivoting extension actuator to bring the pivoting extensions in profile with the body of the device. This will allow the device to be placed into the conduit or tissue defect. The pivoting extension actuator is then released. The device is advanced through the conduit or tissue defect until the pivoting extensions pass the inner most tissue layer needing closure adjacent to the tissue defect or the tip of the conduit. At this point the pivoting extensions will revert back to the rest position. An indicator on the body of the device will alert the physician when this happens. This safety mechanism will ensure the device is not advanced too far through the tissue defect, essentially protecting all the vital structures beyond the tissue defect.
If the device was placed through the conduit, the conduit can then be removed by sliding it over the device. The device is then brought up so that the distal ends of the pivoting extensions appose the innermost tissue layer. As the physician pulls up on the device, the pivoting extensions open by sliding along the innermost tissue layer and sweeping away any vital structures that may be close to the instrument. Alternatively the pivoting extensions can be opened using the collapsible handle connected to the pivoting extension actuator. An indicator on the device alerts the physician that the pivoting extensions are open in their final actuated position. The pivoting extensions are then locked into position stabilizing the device to ensure proper function.
The physician then uses a needle actuator to drive two diametrically opposed flexible nitinol needles housed in the shaft of the instrument out of the ports on the body of the device. The flexible needles are driven in opposite directions through the tissue layers the physician is interested in closing, towards the distal ends of the pivoting extensions. The flexible needles are driven out at a predetermined height and angle to ensure that an adequate amount of tissue is used to close the tissue defect. The flexible needles need to be flexible enough to be manipulated within the body of the device and driven to an adequate distance away from the body of the device to obtain enough tissue for a strong closure. The flexible needles are also configured to have the appropriate stiffness to pierce through the tissue of interest without buckling. The flexible needles will be driven into the coupling channel to be received in the pivoting extensions by a set of couplers attached to the same suture that would be used otherwise to close the port sites. The distal ends of the flexible needles are configured to mate with the couplers and pull the suture back through the tissue adjacent to the tissue defect.
The physician then releases the lock on the pivoting extensions and uses the pivoting extension actuator to bring the pivoting extensions back into profile with the body. The device is then pulled out of the tissue defect, leaving a looped suture through the tissue adjacent to the tissue defect. The physician can then tie the sutures as he or she would normally do in the standard procedure. At any time, the physician can reposition or remove the instrument without placing the sutures. The procedure may be repeated as many times as the physician considers necessary (usually 1 to close the 10 or 12 mm fascial ports and 2 or 3 to close the 25 mm fascial port) after replacing a cartridge on the distal end of the device.
A number of features have been incorporated into the device to ensure the safety of the patient, the physician and the reliability of the device. The device guarantees a good closure by consistently obtaining a sufficient amount of tissue adjacent to the tissue defect every time due to the use of flexible nitinol needles and the geometry of the needle tract. The pivoting extensions have been designed to ensure that all intra-abdominal contents have been swept out of the path of the flexible needles. The pivoting extensions also protect all the contents during the deployment of the flexible needles. To prevent accidental deployments of the flexible needles, the pivoting extensions have to be in locked into position prior to needle deployment. The safety features designed into the device allow it to be used with and without visualization or pneumoperitoneum. Finally, the device was designed so that it would automatically place a suture in less than 30 seconds in 1-2-3 step fashion.
The detailed description set forth below is intended as a description of the presently preferred embodiments of the invention and is not intended to represent the only form in which the present invention may be constructed or utilized. The description sets forth the functions and sequences of steps for constructing and operating the invention. It is to be understood, however, that the same or equivalent functions and sequences may be accomplished by different embodiments and that they are also intended to be encompassed within the scope of the invention.
This invention is an improved system to facilitate the closure of tissue defects created by the insertion of a trocar, sheath, or by any other suitable cause. While detail will be provided to aid in the enablement of the device for closure of laparoscopic fascial port sites, this should not limit the disclosure. Any suitable system or method that functions to close a tissue defect in the body may alternatively be used and should be considered within the scope of this disclosure.
The preferred embodiment of the instrument shown in
Shown in
The pivoting extension actuator 7 having a proximal and distal end is free to slide over the distal end of the needle tract 14 and is rigidly connected to a collapsible handle 4 via a push rod 21 and houses the pivoting extensions 8 distal to the body 5. The pivoting extension actuator 7 is attached to the pivoting extensions 8 and used to actuate the pivoting extensions 8 by bringing said pivoting extensions 8 into contact with the tapered distal end of the needle tracts 14. A locking mechanism 2 shown in
Also shown in
Also shown in
The device is designed to be in profile as shown in
If the device was placed through the conduit 25, the conduit 25 can then be removed by sliding it over the device. As shown in
Once the pivoting extensions 8 are in position three, as shown in
The physician then releases the locking mechanism 2 on the pivoting extensions 8 and uses the collapsible handle 4 to engage the pivoting extension actuator 7 to bring the pivoting extensions 8 back into profile with the body 5. The device is then pulled out of the tissue defect 24, leaving a looped suture 9 through the tissue 20 adjacent to the tissue defect 24. The physician can then tie the suture 9 as he or she would normally do on the standard procedure. At any time, the physician can reposition or remove the instrument without placing the sutures 9. The procedure may be repeated as many times as the physician considers necessary (usually 1 to close the 10 or 12 mm fascial ports and 2 or 3 to close the mm fascial port) after replacing a cartridge on the distal end of the device. A number of features have been designed into the device to ensure the safety of the patient and the physician and the reliability of the device. The device guarantees a good closure by consistently obtaining a predetermined amount of tissue 20 adjacent to the tissue defect 24 every time due to the use of flexible nitinol needles 13 and the geometry of the needle tract 14. The pivoting extensions 8 have been designed to ensure that all intra-abdominal contents 16 have been swept out of the path of the flexible needles 13. The pivoting extensions 8 also protect all the vital contents 16 during the deployment of the flexible needles 13. Enough safety features have been designed into the device, that it can be used with and without visualization or pneumoperitoneum. Finally, the device was designed so that it would automatically place a suture 9 in less than 30 seconds in 1-2-3 step fashion.
As a person skilled in the art will recognize from the previous descriptions and from the figures, modifications and changes can be made to the preferred embodiments of the invention without departing from the scope of this invention.
This application claims the benefit of U.S. Provisional Application Ser. No. 60/A35,265 filed on Aug. 3, 2006 and is hereby incorporated as reference in its entirety.
Number | Date | Country | |
---|---|---|---|
60835265 | Aug 2006 | US |